Zentalis Pharmaceuticals Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Zentalis Pharmaceuticals is a clinical-stage biotechnology company focused on cancer therapeutics. Its lead program, azenosertib, is a WEE1 inhibitor studied for Cyclin E1-positive, platinum-resistant ovarian cancer and is being evaluated as both monotherapy and in combination with other therapies. Early clinical data suggest the drug is generally tolerated and shows anti-tumor activity across multiple tumor types. Based in San Diego, California, the company operates in the biotechnology research field, advancing scientific insights toward clinical cancer candidates that could support oncology care providers and patients. A recent development includes an abstract acceptance at ASCO 2026 for azenosertib in combination with Paclitaxel for platinum-resistant ovarian cancer.